This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
Journal of Hematology & Oncology Open Access 12 April 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Aversa F . Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States. Bone Marrow Transplant 2008; 41: 473–481.
Koh LP, Chao N . Haploidentical hematopoietic cell transplantation. Bone Marrow Transplant 2008; 42 (Suppl 1): S60–S63.
Ichinohe T, Uchiyama T, Shimazaki C, Matsuo K, Tamaki S, Hino M et al. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood 2004; 104: 3821–3828.
Shimazaki C, Ochiai N, Uchida R, Okano A, Fuchida S, Ashihara E et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood 2003; 101: 3334–3336.
Shimazaki C, Fuchida S, Ochiai N, Nakano S, Yamada N, Uchida R et al. Non-T-cell-depleted HLA-haploidentical stem cell transplantation after reduced-intensity conditioning in advanced haematological malignancies based on feto-maternal microchimerism. Br J Haematol 2004; 127: 474–475.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
van den Boogaardt DE, van Rood JJ, Roelen DL, Claas FH . The influence of inherited and noninherited parental antigens on outcome after transplantation. Transpl Int 2006; 19: 360–371.
Matsuoka K, Ichinohe T, Hashimoto D, Asakura S, Tanimoto M, Teshima T . Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+CD25+ T-cell-dependent mechanism. Blood 2006; 107: 404–409.
Opiela SJ, Levy RB, Adkins B . Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens. Blood 2008; 112: 1530–1538.
Stern M, Ruggeri L, Mancusi A, Bernardo ME, de Angelis C, Bucher C et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood 2008; 112: 2990–2995.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kanda, J., Ichinohe, T., Shimazaki, C. et al. Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD. Bone Marrow Transplant 44, 327–329 (2009). https://doi.org/10.1038/bmt.2009.18
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.18
This article is cited by
-
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
Journal of Hematology & Oncology (2016)
-
Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCT
Bone Marrow Transplantation (2011)
-
Haploidentical Transplantation for Leukemia
Current Oncology Reports (2010)